Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Amortization - Intangibles (2024 - 2025)

Coeptis Therapeutics Holdings has reported Amortization - Intangibles over the past 2 years, most recently at -$204365.0 for Q4 2025.

  • Quarterly results put Amortization - Intangibles at -$204365.0 for Q4 2025, up 61.72% from a year ago — trailing twelve months through Dec 2025 was -$238176.0 (changed N/A YoY), and the annual figure for FY2025 was $545635.0, up 152.39%.
  • Amortization - Intangibles for Q4 2025 was -$204365.0 at Coeptis Therapeutics Holdings, down from $250000.0 in the prior quarter.
  • Over the last five years, Amortization - Intangibles for COEPW hit a ceiling of $250000.0 in Q3 2024 and a floor of -$533811.0 in Q4 2024.